BMO raises AMN Healthcare stock target to USD 43.00

Published on 10/20/2026 at 21:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Adjusted EPS reached USD 0.77 in Q2 2026 versus USD 0.30 a year earlier. AMN Healthcare stock costs EUR 36.70 on October 20, 2026.

Analyst target and results

BMO Capital raised its AMN target to USD 43.00 from USD 40.00 on October 9, 2026.
Second-quarter revenue reached USD 673.00 million, up 2.00 percent year over year.
AMN stock costs EUR 36.70 at Lang & Schwarz on October 20, 2026 at 9:09 p.m. CEST.
AMN is scheduled to report third-quarter results on November 5, 2026.

AMN, US0017441017, Illustration mit AI erstellt.

AMN Healthcare Services (ISIN US0017441017) is tied to a higher BMO Capital target of USD 43.00, raised from USD 40.00 on October 9, 2026. Markets Insider reported that analyst Jeffrey Silber retained an Outperform rating while lifting the target. In the second quarter of 2026, revenue reached USD 673.00 million, up 2.00 percent year over year, while adjusted earnings per share rose to USD 0.77 from USD 0.30. AMN stock was trading at EUR 36.70 at Lang & Schwarz on October 20, 2026 at 9:09 p.m. CEST.

Target leaves a measured upside case

The BMO target sits above the latest US market quote, but the comparison uses different currencies and therefore does not translate directly into a euro price objective. On the NYSE, AMN was last quoted at USD 41.26 on October 20, 2026 at 3:13 p.m. ET, according to the market snapshot, with a market capitalization of USD 1.60 billion.

The target increase also stands apart from the broader analyst range. Zacks listed seven analyst targets between USD 28.00 and USD 43.00, with an average of USD 36.57 as of October 16, 2026. The highest target therefore matches BMO Capital's new level, while the average remains below the latest US quote.

Second-quarter demand was uneven

AMN's second-quarter performance combined strength in nurse and allied staffing with pressure in technology services. The Nurse and Allied Solutions segment produced USD 422.00 million of revenue, up 11.00 percent year over year, while Physician and Leadership Solutions generated USD 165.00 million, down 6.00 percent.

The earnings call transcript also showed adjusted EBITDA of USD 73.00 million, equal to a 10.90 percent margin, and adjusted earnings per share of USD 0.77 versus USD 0.30 in the year-ago quarter. Yahoo Finance reported that technology and workforce solutions revenue fell 15.00 percent year over year, highlighting the uneven recovery across AMN's businesses.

November 5 is the next test

AMN has scheduled its third-quarter 2026 results for November 5, 2026, with an earnings release expected after the US market close and a conference call at 5:00 p.m. ET. Financial Times reported the company expects to discuss fourth-quarter 2026 outlook at the call.

Stock valuation and next date

The coming report will test whether the second-quarter improvement can extend beyond nurse and allied staffing. The latest quarter included USD 673.00 million of revenue and USD 21.00 million of net income, while the third-quarter revenue outlook cited in the earnings call was USD 640.00 million to USD 655.00 million.

Stock remains tied to the next report

AMN's next major dated event is the November 5, 2026 results release, while the current euro quotation reflects after-hours trading in Germany. The further course of trading is shown by the continuously updated real-time quote of AMN Healthcare Services stock.